In the pharmaceutical industry, Trifluoperazine (brand name Stelazine) is a high-potency first-generation (typical) antipsychotic from the phenothiazine class. As a pharmacist and manufacturer, I view its role as having two distinct therapeutic “gears” based on the dosage.

At your WHO-GMP facility in Mumbai, Trifluoperazine is typically manufactured in lower strengths (1 mg, 2 mg) for non-psychotic indications and higher strengths (5 mg, 10 mg) for psychiatric disorders.

Therapeutic Use in Anxiety

Trifluoperazine is indeed used for anxiety, but with specific clinical constraints:

• Indication: It is used for the short-term management of non-psychotic anxiety (such as Generalized Anxiety Disorder) in patients who have not responded adequately to first-line treatments like benzodiazepines or SSRIs.

• Target Symptoms: It helps relieve strong feelings of fear, panic, restlessness, and nervousness.

  Dosage Context: For anxiety, it is used in low dosages, typically 2–4 mg per day in divided doses, and should generally not exceed 6 mg per day.

Mechanism: Low-Dose Dopamine Modulation

Trifluoperazine’s effect on anxiety is a result of its ability to “quiet” specific pathways in the brain.

Dopamine Antagonism: It blocks postsynaptic Dopamine $D_2$ receptors in the mesolimbic and mesocortical pathways. By balancing dopamine levels, it reduces “abnormal excitement” and stabilizes mood.

Reticular Activating System (RAS): It depresses the RAS, which is responsible for wakefulness and alertness, contributing to its calming effect on restlessness.

Adrenergic Blockade: It also has central anti-adrenergic properties that help mitigate the physical manifestations of anxiety.

The Pharmacist’s “Technical Warning”

Because it is an antipsychotic being used for a non-psychotic condition, caution is paramount:

• Duration Limit: It should not be used for longer than 12 weeks for anxiety due to the risk of cumulative neurological side effects.

• Extrapyramidal Symptoms (EPS): Even at low doses, it can cause tremors, muscle stiffness, or Tardive Dyskinesia (uncontrollable movements of the tongue or face).

• The “Alcohol” Rule: Alcohol must be strictly avoided as it can dangerously increase sedation and respiratory depression.

• Orthostatic Hypotension: Patients may feel dizzy when standing up; advise them to rise slowly to avoid falls.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

• The “Low-Dose Adjunct” USP: Market the 1 mg and 2 mg strengths as an adjunct for resistant anxiety. This distinguishes the product from high-dose schizophrenia treatments and targets the growing mental health market for “non-responders”.

• Stability for Export: Trifluoperazine is light-sensitive. Utilizing amber-colored PVDC or Alu-Alu blister packaging is essential for maintaining a 36-month shelf life in Zone IVb tropical regions.

• Dossier Support: We provide full CTD/eCTD Dossiers for both low-dose (anxiety) and high-dose (schizophrenia) indications to support your firm’s registration in international psychiatry tenders.